Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancer. - Concepedia

Concepedia

Publication | Closed Access

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancer.

17

Citations

0

References

2010

Year

Koei Chin, K. Kato, T. Yoshikawa, K Yamaguchi, Tetsuo Esaki, Yoshiaki Tsuji, Keisuke Sakai, Masashi Kimura, Rie Ikeda, Y Matsumura

Journal of Clinical Oncology

NanomedicineGastrointestinal OncologyRecurrent Gastric CancerMedicinePharmacologyPhase Ii StudyMolecular OncologyTumor TargetingAnti-cancer AgentCancer TreatmentOncologyCell BiologyCancer ResearchPaclitaxel-incorporating Micellar Nanoparticle

Abstract

4041